Key statistics
On Friday, Bicycle Therapeutics PLC (50BA:FRA) closed at 4.58, 8.53% above its 52-week low of 4.22, set on Feb 17, 2026.
52-week range
| Open | 4.56 |
|---|---|
| High | 4.58 |
| Low | 4.56 |
| Bid | 4.68 |
| Offer | 5.05 |
| Previous close | 4.72 |
| Average volume | 82.20 |
|---|---|
| Shares outstanding | 69.37m |
| Free float | 4.33m |
| P/E (TTM) | -- |
| Market cap | 397.48m USD |
| EPS (TTM) | -3.62 USD |
Data delayed at least 15 minutes, as of Feb 27 2026 14:25 GMT.
More ▼
Press releases
- Bicycle Therapeutics Announces Leadership Transitions for Next Phase of Innovation Across Oncology Pipeline
- Bicycle Therapeutics Highlights 2025 Accomplishments and Strategic Priorities for 2026
- Bicycle Therapeutics Establishes Multiple Strategic Partnerships to Create End-to-End Supply Chain to Support its Wholly Owned Radiopharmaceutical Pipeline
- Ankyra Appoints Sailaja Battula, PhD as Chief Scientific Officer (CSO)
